Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 02, 2024 18:40 ET | Source: Vaxcyte, Inc.

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older

SAN CARLOS, Calif., Sept. 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the...
July 02, 2024 08:30 ET | Source: Vaxcyte, Inc.

Vaxcyte Appoints John Furey to Board of Directors

Vaxcyte appoints John Furey to Board of Directors.
June 02, 2021 13:43 ET | Source: Reports and Data

Vaccines Market Size to Reach USD 73.78 Billion in 2028; Increasing government funding for vaccine production and growing emphasis on immunization are major factors expected to drive the market, Says Reports and Data

New York, June 02, 2021 (GLOBE NEWSWIRE) -- Market Size – USD 42 Billion in 2020 Market Growth – 7.3% Market Trends – Expanding pharmaceutical industry and drive to vaccinate all The global...
March 07, 2019 06:00 ET | Source: Global Market Insights, Inc

Vaccines Market worth over $70bn by 2025: Global Market Insights, Inc.

Selbyville, Delaware, March 07, 2019 (GLOBE NEWSWIRE) -- The vaccines market is estimated to hike from over USD 38 billion in 2018 to over USD 70 billion by 2025, according to a 2019 Global Market...